Browse by Title

Type here to filter the list

P
Panel Discussion
Favorite

Ana Ruiz, PharmD, PhD – Gilead Sciences ### 2360693###Panelist###Executive Director, Head of the Pharmacometrics Group###Gilead Sciences###
Panelist: Ana Ruiz, PharmD, PhD – Gilead Sciences
### @@@ Julia Korell, PhD (she/her/hers) – Metrum Research Group ### 2360694###Panelist###Principal Scientist II###Metrum Research Group###
Panelist: Julia Korell, PhD (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company ### 2360695###Panelist###Vice President and Head of Global PK/PD and Pharmacometrics###Eli Lilly and Company###
Panelist: Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Joga Gobburu, PhD MBA (he/him/his) – University of Maryland ### 2380204###Panelist###Professor###University of Maryland###
Panelist: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/his @@@ Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD ### 2360753###Panelist###Executive Director###Executive Director at Astellas/ Editor-in-Chief, JPKPD###
Panelist: Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD
###
Panel Discussion
Favorite

Neelima Thanneer, MS – BMS ### 2360663###Panelist###Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting###BMS###
Panelist: Neelima Thanneer, MS – BMS
### @@@ Xiaobin Li, M.S – GSK ### 2407936###Panelist###Programming Director, CPMS Programming and Business Excellence###GSK###
Panelist: Xiaobin Li, M.S – GSK
### @@@ Alice Zong, MSPH – Johnson & Johnson ### 2360709###Panelist###Associate Director, Clinical Pharmacology and Pharmacometrics###Johnson & Johnson###
Panelist: Alice Zong, MSPH – Johnson & Johnson
###
Panel Discussion
Favorite

Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University ### 2360723###Panelist###Professor of Pharmacology, Surgery and Medicine###Thomas Jefferson University###
Panelist: Walter K. Kraft, MD (he/him/his) – Thomas Jefferson University
### he/him/his @@@ Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda ### 2360724###Panelist###Professor of Clinical Pharmacology & Global Health###University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda###
Panelist: Catriona Waitt, MBChB, PhD – University of Liverpool, UK and Infectious Diseases Institute, Makerere University, Uganda
### @@@ Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration ### 2360725###Panelist###Clinical Pharmacology Policy Lead ###U.S. Food and Drug Administration###
Panelist: Elimika Pfuma Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers @@@ Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University ### 2407905###Panelist###Professor and Chair###Department of Biomedical Informatics, College of Medicine, The Ohio State University###
Panelist: Lang Li, PhD – Department of Biomedical Informatics, College of Medicine, The Ohio State University
### @@@ Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine ### 2407908###Panelist###Professor of OB/GYN###Indiana University School of Medicine###
Panelist: Sara Quinney, PharmD, PhD (she/her/hers) – Indiana University School of Medicine
### she/her/hers
Panel Discussion
Favorite

Julie A. Stone, PhD – Merck & Co., Inc. ### 2360716###Panelist###Scientific Assoc. VP###Merck & Co., Inc.###
Panelist: Julie A. Stone, PhD – Merck & Co., Inc.
### @@@ Youfang Cao, PhD – Eisai, Inc ### 2360717###Panelist###Director of Pharmacometrics###Eisai, Inc###
Panelist: Youfang Cao, PhD – Eisai, Inc
### @@@ Brian A. Willis, PhD (he/him/his) – Biogen ### 2360718###Panelist###Head of Pharmacometrics###Biogen###
Panelist: Brian A. Willis, PhD (he/him/his) – Biogen
### he/him/his @@@ Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company ### 2360719###Panelist###Sr Director, Global PK/PD and Pharmacometrics###Eli Lilly and Company###
Panelist: Ivelina Gueorguieva, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Stephen Duffull, PhD (he/him/his) – Certara ### 2415651###Panelist###Senior Scientific Advisor###Certara###
Panelist: Stephen Duffull, PhD (he/him/his) – Certara
### he/him/his
Panel Discussion
Favorite

Amita Joshi, PhD (she/her/hers) – Genentech, South San Francisco, CA ### 2360737###Panelist###Vice President, Clinical Pharmacology###Genentech, South San Francisco, CA###
Panelist: Amita Joshi, PhD (she/her/hers) – Genentech, South San Francisco, CA
### she/her/hers @@@ Mirjam Trame, Ph.D (she/her/hers) – Certara ### 2360657###Panelist###Vice President Pharmacometrics###Certara###
Panelist: Mirjam Trame, Ph.D (she/her/hers) – Certara
### she/her/hers @@@ Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA ### 2360738###Panelist###Research Fellow###Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA###
Panelist: Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA
### she/her/hers @@@ Kapil Gadkar, PhD – Genentech ### 2407912###Panelist###Distinguished Scientist, Senior Director###Genentech###
Panelist: Kapil Gadkar, PhD – Genentech
### @@@ C.J. Musante, PhD – Pfizer ### 2407910###Panelist###VP & Global Head of Pharmacometrics & Systems Pharmacology###Pfizer###
Panelist: C.J. Musante, PhD – Pfizer
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###
Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb ### 2457387###Panelist######Bristol Myers Squibb###
Panelist: Anna Kondic, anna.kondic@bms.com – Bristol Myers Squibb
###
Panel Discussion
Favorite

Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK ### 2360727###Panelist###Director###Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK###
Panelist: Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK
### he/him/his @@@ Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration ### 2360704###Panelist###Expert Regulatory Scientist (Systems Pharmacology)###Center for Drug Evaluation and Research, US Food and Drug Administration###
Panelist: Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc. ### 2360730###Panelist###Associate Director/Sr. Principal Scientist###Simulations Plus, Inc.###
Panelist: Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc.
### he/him/his @@@ Tongli Zhang, PhD (he/him/his) – College of Medicine University of Cincinnati ### 2360732###Panelist###Associate Professor Pharmacology & Systems Physiology###College of Medicine University of Cincinnati###
Panelist: Tongli Zhang, PhD (he/him/his) – College of Medicine University of Cincinnati
### he/him/his @@@ Corey J. Bishop, PhD (he/him/his) – Clinical Pharmacology and Pharmacometrics Johnson & Johnson ### 2360731###Panelist###Senior Principal Scientist###Clinical Pharmacology and Pharmacometrics Johnson & Johnson###
Panelist: Corey J. Bishop, PhD (he/him/his) – Clinical Pharmacology and Pharmacometrics Johnson & Johnson
### he/him/his
Panel Discussion
Favorite

Joy C. Hsu, PhD – Genentech ### 2360676###Panelist###Director, Clinical Pharmacology and Pharmacometrics###Genentech###
Panelist: Joy C. Hsu, PhD – Genentech
### @@@ Hao Zhu, PhD – ISoP ### 2360688###Panelist###ISoP Board Member###ISoP###
Panelist: Hao Zhu, PhD – ISoP
### @@@ Francesco Brizzi, PhD (he/him/his) – Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland ### 2360747###Panelist###Senior Scientist###Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland###
Panelist: Francesco Brizzi, PhD (he/him/his) – Predictive Modelling and Data Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Switzerland
### he/him/his @@@ Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc. ### 2343539###Panelist###Senior Product Engineer###DeepPumas, Pumas-AI Inc.###
Panelist: Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc.
### he/him/his
Panel Discussion
Favorite

Hao Zhu, PhD – ISoP ### 2360688###Panelist###ISoP Board Member###ISoP###
Panelist: Hao Zhu, PhD – ISoP
### @@@ Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy ### 2408503###Panelist###Professor###University of Michigan College of Pharmacy###
Panelist: Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy
### @@@ Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus ### 2380006###Panelist###Platform Scientific Lead###Pharmetheus###
Panelist: Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus
### she/her/hers @@@ Yuan Xiong, PhD – Johnson & Johnson ### 2380009###Panelist###Director###Johnson & Johnson###
Panelist: Yuan Xiong, PhD – Johnson & Johnson
### @@@ Neelima Thanneer, MS – BMS ### 2360663###Panelist###Executive Director, Head of Data Science and Clin Pharm Analysis & Reporting###BMS###
Panelist: Neelima Thanneer, MS – BMS
### @@@ Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc. ### 2360697###Panelist###Manager, Pharmacometrics & Systems Pharmacology###Pfizer, Inc.###
Panelist: Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc.
### she/her/hers
Panel Discussion
Favorite

Jingqi Gong, PhD (she/her/hers) – GlaxoSmithKline ### 2360666###Panelist###Associate Director, Quantitative Systems Pharmacology###GlaxoSmithKline###
Panelist: Jingqi Gong, PhD (she/her/hers) – GlaxoSmithKline
### she/her/hers @@@ Oleg Demin Jr (he/him/his) – InSysBio CY ### 2360667###Panelist###Scientific Director, Oncology & Immuno-Oncology Quantitative Systems Pharmacology###InSysBio CY###
Panelist: Oleg Demin Jr (he/him/his) – InSysBio CY
### he/him/his @@@ Richard Allen, PhD – Pfizer ### 2360668###Panelist###Research Fellow and Quantitative Systems Pharmacology Lead###Pfizer###
Panelist: Richard Allen, PhD – Pfizer
### @@@ Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Panelist###Senior Director & Head of Translational Disease Modeling - US###Sanofi###
Panelist: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hers
Panel Discussion
Favorite

Richard Allen, PhD – Pfizer ### 2360668###Panelist###Research Fellow and Quantitative Systems Pharmacology Lead###Pfizer###
Panelist: Richard Allen, PhD – Pfizer
### @@@ Brian Schmidt ### 2407942###Panelist#########
Panelist: Brian Schmidt
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###
Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus ### 2380006###Panelist###Platform Scientific Lead###Pharmetheus###
Panelist: Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus
### she/her/hers @@@ Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Panelist###Senior Director & Head of Translational Disease Modeling - US###Sanofi###
Panelist: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hers
Panel Discussion
Favorite

Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital ### 2379985###Speaker###Deputy Director###Drug Clinical Trial Center, Peking University Third Hospital###
Speaker: Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital
### he/him/his @@@ Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche ### 2413383###Speaker###Expert Scientist###F. Hoffmann-La Roche###
Speaker: Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche
### he/him/his @@@ Aleksandra Galetin, PhD (she/her/hers) – University of Manchester ### 2379986###Speaker###Professor of Translational Pharmacokinetics ###University of Manchester###
Speaker: Aleksandra Galetin, PhD (she/her/hers) – University of Manchester
### she/her/hers @@@ Lixia Zhang, PhD – FDA ### 2413382###Speaker###Staff Fellow###FDA###
Speaker: Lixia Zhang, PhD – FDA
###
Parameter Selection and Uncertainty Quantification Techniques for Pharmacokinetic Models
Favorite

Ralph Smith, PhD – North Carolina State University ### 2360699###Speaker###Distinguished University Professor, Professor of Mathematics###North Carolina State University###
Speaker: Ralph Smith, PhD – North Carolina State University
###
Pharmacometrics for the Win: How Modeling Helps Demonstrate Efficacy in Alzheimer’s Disease and Provides Insight into Drug Activity
Favorite

Brian A. Willis, PhD (he/him/his) – Biogen ### 2360718###Speaker###Head of Pharmacometrics###Biogen###
Speaker: Brian A. Willis, PhD (he/him/his) – Biogen
### he/him/his
Pharmacometrics Modeling via Physics-Informed Neural Networks: Integrating Time-Variant Absorption Rates and Fractional Calculus for Enhancing Prediction Accuracy
Favorite

Nazanin Ahmadi Daryakenari, PhD Candidate (she/her/hers) – Biomedical Engineering, Brown University ### 2360673###Speaker###Research Assistant###Biomedical Engineering, Brown University###
Speaker: Nazanin Ahmadi Daryakenari, PhD Candidate (she/her/hers) – Biomedical Engineering, Brown University
### she/her/hers
Pharmacometrics Workflow: Points to Consider for Efficient, High-Quality, and Reproducible Analyses
Favorite

Jace Nielsen, Pharm.D. – Astellas ### 2360662###Speaker###Exploratory Development Fellow###Astellas###
Speaker: Jace Nielsen, Pharm.D. – Astellas
###
Positron Emission Tomography and Tracer Kinetic Modeling for Quantitative Molecular Imaging in Drug Discovery and Development
Favorite

Marc D. Normandin, PhD (he/him/his) – Yale University ### 2360745###Speaker###Director of Yale PET Core, Associate Professor of Radiology & Biomedical Imaging###Yale University###
Speaker: Marc D. Normandin, PhD (he/him/his) – Yale University
### he/him/his
Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure- Response Analyses Underutilized?
Favorite

Ahmed H. Salem, PhD, FCP – Abbvie ### 2384742###Speaker###Senior Research Fellow###Abbvie###
Speaker: Ahmed H. Salem, PhD, FCP – Abbvie
###
Practical Tools for Model Calibration with SimBiology, MathWorks
Favorite

Fulden Buyukozturk, PhD – MathWorks ### 2343543###Speaker###Principal Engineer###MathWorks###
Speaker: Fulden Buyukozturk, PhD – MathWorks
###
Preconference Concluding Remarks
Favorite

Joy C. Hsu, PhD – Genentech ### 2360676###Speaker###Director, Clinical Pharmacology and Pharmacometrics###Genentech###
Speaker: Joy C. Hsu, PhD – Genentech
### @@@ Mark Lovern, PhD (he/him/his) – InSilicoTrials ### 2343536###Speaker###Chief Platform Officer###InSilicoTrials###
Speaker: Mark Lovern, PhD (he/him/his) – InSilicoTrials
### he/him/his
Presentation of ISoP Awards & Induction of Fellows
Favorite

Nahor Haddish-Berhane ### 2407516###Speaker#########
Speaker: Nahor Haddish-Berhane
###
President's Address
Favorite

Jennifer Monroy, CAE – ISoP ### 2513798###Speaker###Executive Director###ISoP###
Speaker: Jennifer Monroy, CAE – ISoP
### @@@ Vijay Ivaturi, PhD – PUMAS Inc ### 2343541###Speaker###Principal scientist PUMAS###PUMAS Inc###
Speaker: Vijay Ivaturi, PhD – PUMAS Inc
###
Protein Language Models to incorporate PKPD considerations in early antibody design and generation
Favorite

Louis Joslyn, PhD – Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech ### 2453718###Speaker###Principal Scientist###Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech###
Speaker: Louis Joslyn, PhD – Preclinical and Translational Pharmacokinetics/Pharmacodynamics, Genentech
###